Naploy Corp. (NPLY) stock
Price, market cap and P/E appear here once daily prices are connected.
Naploy Corp. grew revenue 127.6% to $18.10K over the twelve months to Jul 31, 2026.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jul 31, 2026
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $18.10K
- Net income
- -$31.68K
- EPS, diluted
- -$0.01
- Book value per share
- -$0.01
- Diluted shares
- 4M
Valuation needs the share price. It fills in once daily prices are connected.
Four years at a glance
Fiscal years 2023 to 2026, USD
Revenue
Operating income
Net income
EPS, diluted
About Naploy
Services-Health Services
Naploy Corp. is a digital health platform developer that operates the Naploy App across mobile and web interfaces. The application features a curated health news blog covering topics such as nutrition, fitness, disease management, and medical research. Additionally, it offers an artificial intelligence-driven symptom diagnostic tool designed to provide users with lists of potential health conditions for informational purposes. The company also provides a clinic search assistance service that connects individuals with medical institutions, as well as paid contextual advertising services, including banner and pop-up ads, for healthcare providers.
Company profile, executives and historyNaploy stock: common questions
What is NPLY's P/E ratio?
Naploy lost money over the twelve months to Jul 31, 2026 (diluted EPS -$0.01), so it has no meaningful P/E ratio.
How much revenue does Naploy make?
Naploy reported revenue of $18.10K for the twelve months to Jul 31, 2026, up 127.6% from a year earlier.
Does Naploy pay a dividend?
No. Naploy has not paid a cash dividend over the last twelve months.
Who are Naploy's competitors?
Companies most similar to Naploy by business, industry and size include MDXR, HSCT, DSFT, NTCS, SMIO.
See a number that looks wrong?